This company listing is no longer active
Lysogene Management
Management criteria checks 3/4
Lysogene's CEO is Karen Pignet-Aiach, appointed in Jan 2009, she has a tenure of 14.5 years. She directly owns 2.21% of the company’s shares, worth €109.55K. The average tenure of the management team and the board of directors is 4.8 years and 4.2 years respectively.`
Key information
Karen Pignet-Aiach
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 14.5yrs |
CEO ownership | 2.2% |
Management average tenure | 4.8yrs |
Board average tenure | 4.2yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -€7m |
Mar 31 2022 | n/a | n/a | -€10m |
Dec 31 2021 | €893k | €324k | -€14m |
Sep 30 2021 | n/a | n/a | -€12m |
Jun 30 2021 | n/a | n/a | -€11m |
Mar 31 2021 | n/a | n/a | -€8m |
Dec 31 2020 | €3m | €320k | -€5m |
Sep 30 2020 | n/a | n/a | -€4m |
Jun 30 2020 | n/a | n/a | -€2m |
Mar 31 2020 | n/a | n/a | -€3m |
Dec 31 2019 | €829k | €320k | -€4m |
Sep 30 2019 | n/a | n/a | -€5m |
Jun 30 2019 | n/a | n/a | -€6m |
Mar 31 2019 | n/a | n/a | -€8m |
Dec 31 2018 | €1m | €310k | -€11m |
Sep 30 2018 | n/a | n/a | -€14m |
Jun 30 2018 | n/a | n/a | -€17m |
Mar 31 2018 | n/a | n/a | -€17m |
Dec 31 2017 | €981k | €310k | -€18m |
Sep 30 2017 | n/a | n/a | -€15m |
Jun 30 2017 | n/a | n/a | -€13m |
Mar 31 2017 | n/a | n/a | -€10m |
Dec 31 2016 | €3m | €280k | -€7m |
Compensation vs Market: Insufficient data to establish whether Karen's total compensation is reasonable compared to companies of similar size in the French market.
Compensation vs Earnings: Karen's compensation has been consistent with company performance over the past year.
CEO
Karen Pignet-Aiach (52 yo)
14.5yrs
Tenure
€893,230
Compensation
Mrs. Karen Pignet-Aiach, MBA, has been Chairman of Lysogene S.A. since May 22, 2019 and is its Chief Executive Officer since May 20, 2019. Mrs. Pignet-Aiach serves as Chief Executive Officer and Director o...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 14.5yrs | €893.23k | 2.21% € 109.5k | |
Chief Scientific Officer | 5.2yrs | no data | no data | |
Chief Regulatory affairs | 4.5yrs | no data | no data | |
Chief Clinical Officer | 1.2yrs | no data | no data |
4.8yrs
Average Tenure
Experienced Management: LYS's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 4.2yrs | €893.23k | 2.21% € 109.5k | |
Non-Executive Independent Director | less than a year | no data | no data | |
Non-Executive Independent Director | 5.3yrs | €40.00k | no data | |
Member of Clinical Advisory Board | 5.8yrs | no data | no data | |
Member of Scientific Advisors | no data | no data | no data | |
Member of Clinical Advisory Board | 5.8yrs | no data | no data | |
Non-Executive Independent Director | 3.8yrs | €68.67k | no data | |
Member of Scientific Advisor | no data | no data | no data | |
Non-Executive Independent Director | less than a year | no data | no data |
4.2yrs
Average Tenure
54yo
Average Age
Experienced Board: LYS's board of directors are considered experienced (4.2 years average tenure).